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1.	Introduction	
It	 has	 been	 shown	 that	 high	 resolution	 magic	 angle	 spinning	 (HR-MAS)	 NMR	 allows	 to	
metabolically	characterize	biopsies	from	different	tissues	like	brain,	prostate,	liver,	or	muscle	
(1).	 Fast	 spinning	 around	 an	 axis	 inclined	 at	 the	magic	 angle	 (54.7°)	 averages	 orientation	
dependent	effects,	thereby	reducing	the	spectral	linewidth.	
However,	 HR-MAS	 spectra	 from	 tissues	 of	 most	 organs	 show	 strong	 contributions	 from	
broad	lipid	signals.	Although	these	may	convey	important	information	themselves,	they	are	
overlapping	metabolite	 regions.	This	could	hamper	metabolite	estimation	and	may	 lead	to	
misinterpretation.	 Metabolite	 quantification	 and	 metabonomic	 analysis	 would	 therefore	
benefit	from	a	separation	of	lipid	resonances	from	those	of	small	metabolites.	
Spectral	 fitting	may	 be	 applied	 for	 separating	 lipids	 from	 small	metabolites	 (2).	 However,	
solely	fitting	the	lipid	contribution	in	spectra	that	contain	also	small	metabolites	is	prone	to	
artificial	 inclusion	of	metabolite	contributions	 into	the	 lipid	fit.	Fitting	simultaneously	small	
metabolites	 and	 lipids	 has	 many	 advantages,	 but	 it	 also	 introduces	 bias	 as	 to	 which	
metabolites	to	include	and	also	on	the	included	metabolites	themselves,	which	is	avoided	in	
metabonomic	analysis.		
The	Carr-Purcell-Meiboom-Gill	 (CPMG)	sequence	 is	commonly	used	as	a	T2-filter	to	reduce	
broad	 components	 and	 therefore	 also	 fat	 contributions	 from	 spectra,	 taking	 advantage	of	
the	 short	 T2	 relaxation	 times	of	 lipids(3).	However,	 long	echo	 times	would	be	 required	 to	
eliminate	most	of	the	lipids(4),	with	consequently	(A)	reduced	signal	to	noise	also	for	small	
metabolites,	(B)	a	T2	dependency	of	peak	intensities	impeding	metabolite	quantification,	(C)	
heating	of	the	sample,	(D)	J-evolution	of	spins,	and	(E)	losing	all	information	on	lipids.		
Besides	 shorter	 T2,	 lipids	 differ	 also	 from	 small	 metabolites	 in	 terms	 of	 much	 slower	
diffusion.	 Fast	diffusing	 small	metabolites	may	 therefore	be	 separated	 from	slow	diffusing	
lipids	 by	 NMR	 diffusion	 measurements.	 It	 has	 previously	 been	 shown	 that	 subtracting	 a	
strongly	diffusion	weighted	 (DW)	 spectrum	 from	a	 low	DW	spectrum	can	 lead	 to	a	 strong	
reduction	or	even	elimination	of	spectral	contributions	from	lipids.	This	was	applied	in	high	
resolution	 liquid	state	NMR	measurements	of	proteins	 (5),	carbohydrates	 (6),	as	well	as	 in	
rat	(7)	and	human	blood	plasma	(8),	and	in	in-vivo	measurements	of	the	brain(9).	
Moreover,	an	almost	complete	separation	of	small	molecules	and	lipids	may	be	obtained	by	
a	combination	of	both	physical	differences,	i.e.	combining	diffusion	gradient	editing	and	T2-
filter	 (10).	 The	 two	 effects	 have	 been	 combined	 in	 oil-water	 samples	 (11)	 for	 separate	
measurements	 of	 individual	 T2	 attenuations	 of	 the	 two	 components,	 and	 conversely	 in	
vegetables	 for	 improved	 separated	 determination	 of	 diffusion	 constants	 (12).	 In	 liver	
biopsies,	 the	 two	 effects	 have	 been	 combined	 for	 distinguishing	 lipid	 and	 low	 molecular	
weight	resonances	for	both	improved	relaxation	and	diffusion	constant	estimations,	as	this	
can	provide	 information	of	metabolite	 changes	 inside	 the	 tissue	 (4).	 Liu	et	 al.	 showed	 the	
possibility	 to	 separate	 the	 high	 molecular	 weight	 molecules	 by	 diffusion	 editing,	 the	 low	
molecular	weight	molecules	 by	 relaxation	editing	 and	 applied	 a	 combined	editing	method	
(combined	diffusion	and	T2-filter	 sequence)	 in	human	blood	plasma	 for	better	 lipoprotein	
analysis(8).	
However,	to	the	best	of	our	knowledge,	diffusion	gradient	editing	alone	or	its	combination	
with	a	T2-filter	has	not	yet	been	applied	 in	HR-MAS	spectra	of	biopsies	 for	obtaining	 lipid-
free	small	metabolite	spectra.	
The	aim	of	our	 study	was	 therefore	 to	 investigate	different	diffusion	editing	 techniques	 in	
order	 to	 employ	 diffusion	 differences	 for	 separating	 lipid	 from	 small	 metabolite	
contributions	 in	 the	 spectra	 of	 various	 tissues	 for	 unbiased	 metabonomic	 analysis.	 Thus	
NMR-diffusion	 measurements	 applying	 different	 gradient	 strengths	 were	 performed	 on	
biopsies	of	human	muscle.	 Spectra	obtained	at	 strong	DW	solely	 consisting	of	 lipid	 signals	
were	 subtracted	 from	 those	 obtained	 at	 low	 DW	 including	 both,	 small	 metabolites	 and	
lipids.	 	 In	addition,	the	study	aimed	at	simultaneously	utilizing	diffusion	and	T2	differences	
(12)	between	small	metabolites	and	 lipids	 for	an	efficient	 separation.	Therefore	additional	
measurements	were	 performed	 on	 biopsies	 from	 different	 organs	 and	 animals	 combining	
both	effects.	
			
In	order	to	probe	the	impact	of	this	editing	method,	it	was	applied	in	a	reproducibility	study	
of	 muscle	 spectra	 including	 chemometric	 analyses.	 The	 metabolite	 variability	 of	 two	
specimen	of	 the	 same	muscle	was	 investigated	before	and	after	 removing	 the	 lipid	peaks.	
Secondary	aim	was	 to	determine	 to	what	extent	 the	metabolite	profile	of	 a	 single	muscle	
specimen	can	be	considered	representative	for	the	tissue.	
	
2.	Material	and	Methods	
2.1	Biopsies		
In	 order	 to	 test	 the	 lipid	 removal	 method	 under	 very	 different	 conditions,	 biopsies	 from	
different	organs	and	animals	were	analyzed.	The	diffusion	editing	technique	was	tested	and	
improved	 in	human	and	pork	muscle,	 sheep	brain,	 and	human	 liver	 biopsies.	 The	method	
was	 then	 applied	 in	 a	 reproducibility	 study	 on	 human	 muscle.	 For	 all	 measurements	 on	
human	and	animal	biopsies	ethical	approval	was	obtained.	
	
2.1.1	Human	Muscle	Biopsy	-	Reproducibility	study	
The	 human	muscle	 biopsies	 included	 in	 this	 study	were	measured	 as	 part	 of	 an	 on-going	
clinical	trial	involving	healthy	adults	(13).	Skeletal	muscle	specimens	were	obtained	from	the	
vastus	 lateralis	 by	 the	 Bergstrom	 technique	 under	 local	 anaesthesia	 (2%	 lidocaine)	 as	
described	 previously	 (14).	 After	 retrieval,	 specimens	 were	 immediately	 trimmed	 from	 fat	
with	a	magnification	lens	(10x),	flash	frozen	in	liquid	nitrogen	and	stored	at	-80	degrees	until	
analyzed.	 As	 each	 needle	 biopsy	 pass	 allows	 the	 collection	 of	 multiple	 specimens	 with	
possible	distances	of	a	 few	millimetres,	8	pairs	of	biopsies	 (4.1	±2.4mg)	were	used	 for	 the	
reproducibility	analyses	(labelled	"same	needle	biopsies").		
2.1.2	Sheep	brain	biopsy		
Five	sheep	brain	biopsies	(10.5mg±1.8mg)	were	obtained	by	stereotactic-guided	brain	biopsy	
collection	 from	 thalamus	 and	 brainstem.	 Out	 of	 these	 five	 biopsies,	 three	 were	 from	 a	
slaughtered	healthy	 sheep	collected	 two	hours	after	death,	 and	 two	were	 from	 two	 living	
and	 healthy	 sheep.	 70%	 ethanol	was	 used	 for	 aseptic	 skin	 preparation.	 All	 these	 biopsies	
were	simultaneously	analyzed	for	an	on-going	sheep	brain	clinical	study.		
2.1.3	Human	liver		
Two	human	 liver	biopsies	were	obtained	 from	an	ongoing	hepatic	 steatosis	 study	 (approx.	
5mg).	 The	 two	 subjects	 showed	 80%	 and	 50%	 steatosis	 in	 histology.	 The	 liver	 biopsy	was	
performed	transcutaneously	with	a	17G	Menghini	needle	after	sonography	localization	and	
local	anesthesia	with	lidocaine.	The	tissue	was	kept	unfixed	and	frozen	in	TissueTek.		
2.1.4	Pork	muscle		
Fresh	 tissue	 samples	 of	 three	 pork	 muscles	 (approx.	 8mg)	 from	 commercial	 meat	 were	
obtained	to	optimize	measurement	parameters.		
2.2	1H	High	Resolution	Magic	Angle	Spinning	(HR-MAS)	NMR		
1H	HR-MAS	NMR	experiments	were	performed	on	a	Bruker	Avance	II	spectrometer	(Bruker	
Karlsruhe,	Germany)	operating	at	a	 resonance	 frequency	of	500.13	MHz	using	a	4	mm	HR	
MAS	 dual	 inverse	 1H	 /	 13C	 probe	 with	 a	 Magic	 Angle	 gradient.	 The	 measurements	 were	
performed	 between	 277	 and	 282	 Kelvin	 according	 to	 the	 tissue	 type.	 In	 a	 preceding	
experiment	 the	 temperature	 control	 was	 calibrated	 under	 same	 MAS	 conditions	 using	 a	
sample	of	4%	MeOH	in	MeOD-d4.	Bruker	TOPSPIN	software	(version	2.1,	patch	level	5)	was	
used	to	acquire	and	process	the	NMR	data.	For	all	measurements	the	tissue	was	washed	and	
placed	 together	 with	 D2O-based	 phosphate	 buffered	 saline	 (PBS,	 pH=7,	 50mM)	 into	 the	
zirconium	MAS	rotor	using	a	12	μl	insert.	
	
2.2.1	CPMG	(T2-filter)	
CPMG	measurements	with	presaturation	of	the	water	signal	were	performed	on	all	samples	
("cpmgpr1d"	from	the	Bruker	pulse-program	library).	The	measurements	were	performed	at	
an	echo	time	(TE)	of	76.8	ms	(192	loops,	rotor-synchronized	interpulse	delay	of	0.4	ms)	and	a	
recycle	delay	of	4s,	with	a	magic	angle	 spinning	 speed	of	5kHz.	Each	CPMG	spectrum	was	
acquired	applying	512	transients,	a	spectral	width	of	7002.8	Hz	and	a	data	size	of	64K	points.	
These	measurements	were	used	as	reference	for	spectral	quality	and	were	employed	for	the	
reproducibility	study	with	and	without	subtraction	of	the	lipid	contribution.	
	
Additional	 CPMG	 measurements	 were	 performed	 on	 pork	 biopsies	 for	 parameter	
optimization,	modifying	TE,	the	number	of	loops	and	the	interpulse	delay	time	for	each	loop.	
The	four	following	combinations	were	used:	(1)	TE	of	76.8ms	with	192	loops	of	0.4ms;	(2)	TE	
of	152ms	with	380	 loops	of	0.4ms;	 (3)	TE	of	152ms	with	38	 loops	of	4ms;	 (4)	TE	of	760ms	
with	380	individual	loops	of	2ms	each.	
	
2.2.2	2D-Diffusion	
2.2.2.1	2D-diffusion	for	investigating	diffusion	properties	and	for	"internal"	lipid	removal	
Diffusion	 measurements	 were	 first	 performed	 using	 a	 modified	 2D	 stimulated	 echo	
experiment	with	bipolar	gradient	pulses	and	longitudinal	eddy	current	delay	("ledbpgp2s2d"	
from	the	Bruker	pulse-program	library),	at	a	magic	angle	spinning	speed	of	8	kHz.	The	higher	
spinning	 speed	 was	 selected,	 because	 preceding	 measurements	 demonstrated	 a	 higher	
stability	of	the	2D-diffusion	data.	Diffusion	times	Δ	were	50ms	and	200ms	and	the	gradient	
pulse	 length	δ	was	6ms.	 Linear	 ramps	of	64	different	 values	of	 sinusoidal	 gradient	pulses,	
varying	from	0.6	to	32	G/cm,	were	used.	16	scans	were	acquired	at	every	gradient-strength	
with	a	recycle	delay	of	2s.	
The	 2D-diffusion	 measurements	 were	 processed	 conventionally	 to	 create	 and	 analyze	
pseudo-2D	 DOSY	 spectra,	 using	 Bruker	 Dynamics	 Center	 2.0.8. In	 addition	 the	 individual	
spectra	 of	 the	 64	 different	 DW	 were	 investigated.	 Spectra	 at	 stronger	 gradients,	 which	
exhibited	 purely	 lipid	 signals,	 were	 added,	 yielding	 a	 pure	 lipid	 spectrum	with	 good	 SNR.	
Depending	on	 the	number	of	 added	 spectra,	 the	weightings	of	different	 lipid	 components	
vary,	if	the	diffusion	constants	are	different.	It	turned	out	that	for	Δ	=	50ms	ideally	the	last	
20	 spectra	 could	 be	 added	 to	 yield	 a	 pure	 lipid	 spectrum	 [see	 results	 section	3.2.2].	 This	
summed	spectrum	was	then	subtracted	from	the	summed	spectrum	at	low	gradient	strength	
(the	first	20	individual	spectra	of	the	series	were	selected	for	best	SNR).		
2.2.2.2	2D-diffusion	for	lipid	removal	from	CPMG	spectra	for	reproducibility	study	
The	 2D-diffusion	 sequence	 and	 the	 described	 add/subtract	 procedure	 were	 applied	 in	
spectra	 from	human	muscle	biopsies.	 For	 same	needle	biopsy	 samples,	 the	 lipid	 spectrum	
from	2D-Diffusion	was	obtained	on	only	one	biopsy	of	each	pair	and	then	subtracted	from	
the	CPMG	measurements	of	both	biopsies	after	individual	scaling	of	each	lipid	peak.	
2.2.3	1D-Diffusion	
Additional	 measurements	 were	 performed	 at	 a	 spinning	 speed	 of	 5	 kHz	 on	 pork	muscle,	
sheep	 brain	 and	 human	 liver	 biopsies	 combining	 1D	 and	 2D	 diffusion	 sequences	 with	 a	
CPMG	 train	 as	 a	 T2	 filter.	 Each	 1D-diffusion	 spectrum	 was	 acquired	 applying	 1024	
acquisitions,	a	spectral	width	of	6009.6	Hz	and	a	data	size	of	32K	points.	1D-measurements	
were	performed	twice,	once	with	very	 low	DW	(0.1	G/cm)	and	once	with	strong	weighting	
(20	 G/cm	 or	 32	 G/cm),	 yielding	 a	mixed	 small	metabolite/lipid	 spectrum	 and	 a	 pure	 lipid	
spectrum,	respectively,	both	with	very	good	SNR.	The	high-diffusion-weighted	spectrum	was	
scaled	 to	 the	 lipid	 peak	 at	 1.3ppm	 of	 the	 low-diffusion-weighted	 spectrum,	 and	 was	
subtracted	from	the	low-weighted	spectrum,	in	order	to	get	a	lipid-free	spectrum.		
	
2.2.4	Post-processing	
For	all	spectra,	the	co-added	free	induction	decays	(FIDs)	were	exponentially	weighted	with	
a	line	broadening	factor	of	1.0	Hz,	Fourier-transformed,	phased	and	frequency	calibrated	to	
creatine	at	3.03	ppm	to	obtain	the	1H	NMR	spectra.	
	
2.3	Muscle	data	analysis	
Using	 literature	 references	 (15-21)	 and	 our	 own	 additional	 2D	 correlation	 spectroscopy	
(1H1H-TOCSY)	 measurements,	 an	 overall	 of	 18	 metabolites	 and	 11	 lipid	 resonances	 were	
assigned.		
For	chemometric	analysis	of	the	muscle	biopsies	for	the	reproducibility	study,	a	total	of	63	
buckets	 (between	0.95	and	8.62	ppm)	were	selected,	with	a	variable	size	according	 to	 the	
peak	width	(see	supplementary	material,	 figure	S1).	Spectral	regions	comprising	only	noise	
and	pure	lipid	regions	were	excluded	from	all	analyses	to	facilitate	a	comparison	of	the	small	
metabolite	content	from	the	original	and	lipid-subtracted	CPMG	spectra.	 In	addition,	some	
spectra	were	 contaminated	by	 lidocaine,	 the	 anaesthetic	 agent.	 Five	 spectral	 regions	with	
potential	contributions	from	lidocaine	resonances	(peaks	at	1.37,	2.2,	3.37,	4.45,	7.21,	7.26	
ppm)	were	 also	 excluded	 from	 the	 analysis.	 The	buckets	were	 normalized	by	 probabilistic	
quotient	normalization	(PQN)	(22)	and	scaled	with	Pareto	scaling,	which	keeps	the	influence	
of	noise	low,	while	decreasing	contributions	from	intense	peaks	and	increasing	the	weight	of	
intermediate	 peaks	 (23).	 MatLab	 (R2011b,	 The	 MathsWorks	 Inc.)	 was	 used	 for	 statistical	
analysis.		
	
The	whole	muscle	analysis	(bucketing,	normalization,	scaling	and	statistical	analysis)	was	first	
done	on	the	pure	CPMG	spectra,	and	then	repeated	with	the	lipid-subtracted	CPMG	spectra	
[see	 2.2.2.2],	 to	 evaluate	 the	 influence	 of	 the	 lipid	 removal	 on	 the	 reproducibility	
metabonomic	study.	
	
3.	Results	and	Discussion	
The	 lipid	 removal	 edited	 method	 was	 first	 applied	 with	 2D-diffusion	 measurements	 in	
human	muscle	biopsies	to	investigate	and	account	for	the	impact	of	differences	in	diffusion	
times.	The	 lipid	 removal	was	 then	 improved	by	 combining	a	1D	diffusion	 sequence	with	a	
CPMG	train	as	T2	filter	and	tested	 in	several	organs.	Finally,	 the	applicability	and	potential	
value	of	 the	 lipid	 removal	 procedure	was	 tested	 in	 a	 small	 reproducibility	 study	on	 same-
needle	biopsies.	
3.1	2D-Diffusion	of	human	muscle	
The	conventional	analysis	of	the	2D-diffusion	measurements	demonstrated	–	as	expected	–	
clear	differences	between	small	metabolites,	which	diffuse	faster,	and	lipid	resonances	(see	
Fig.	1).	The	results	also	show	additional	smaller	differences	between	lipid	resonances,	which	
may	 lead	 to	 slightly	 varying	 lipid	 contributions	 in	 high	 DW	 spectra,	 depending	 on	 the	
diffusion	 weighting,	 or	 depending	 on	 the	 number	 of	 summed	 spectra	 from	 2D	
measurements	(see	next	paragraph).		
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure	1:	A	2D-DOSY	plot	of	human	muscle,	with	the	corresponding	1D-CPMG	spectrum	shown	above.	
	
3.2	2D-Diffusion	lipid	removal	
3.2.1	2D-diffusion	for	investigating	diffusion	properties	and	for	"internal"	lipid	removal		
The	 lipid	 removal	 procedure	 was	 first	 applied	 on	 human	 muscle	 using	 2D-diffusion	
measurements	by	subtracting	high-diffusion-weighted	from	low-diffusion-weighted	spectra.		
Different	numbers	of	spectra	with	strong	and	weak	DW,	respectively,	were	added	from	the	
pseudo	 2D	 data,	 (1)	 to	 obtain	 sufficient	 SNR,	 (2)	 to	 determine	 and	 potentially	 adjust	 for	
slightly	different	spectral	contributions	of	lipid	moieties	due	to	different	diffusion	constants.	
It	turned	out	that	the	number	of	added	spectra	had	only	a	minor	influence	on	the	spectral	
lipid	contributions.		
An	example	for	the	subtraction	is	shown	in	figure	2.	The	lipid	spectrum	subtraction	removes	
the	shoulder	from	the	creatine	peak	at	3.0	ppm,	and	effectively	suppresses	the	lipid	broad	
component	underneath	the	choline,	taurine	and	glycerophosphocholine	(GPC)	peaks	(Fig	2,	
insert).		The	strong	overlap	of	the	lactate	peak	at	1.3ppm	or	leucine,	isoleucine	and	valine	at	
~1.0ppm	with	lipids	is	similarly	strongly	reduced.	The	lipid	peaks	at	0.9	and	2.0ppm	are	well	
5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
suppressed,	 but	 small	 lipid	 residues	 remain,	 which	 are	 –	 besides	 residual	 artefacts	 –	
probably	partly	due	to	mobile	lipids	(19).	Nevertheless,	the	residues	still	impede	metabolite	
quantification	or	 inclusion	in	chemometric	methods.	Therefore,	for	a	chemometric	analysis	
of	small	metabolites,	the	pure	lipid	regions	(0.9	and	1.2ppm)	need	to	be	omitted.	However,	
the	procedure	yields	clearly	reduced	lipid	contributions	for	several	metabolites	like	lactate	at	
1.33ppm,	choline,	GPC,	taurine,	or	creatine	and	may	thus	 lead	to	more	reliable	metabolite	
estimations,	while	at	the	same	time	maintaining	maximum	signal	strength	without	relaxation	
damping,	 which	 also	 hampers	 metabolite	 quantification.	 Furthermore,	 the	 pure	 lipid	
spectrum	from	the	2D	diffusion	data	can	be	analyzed	separately,	besides	 the	possibility	 to	
perform	a	regular	diffusion	analysis.		
	
#	 Lipid	Part	 ppm	
1	 ω-CH3		 0.91	
2		 -(CH2)n	 1.3	
3		 β-CH2	 1.59	
4		 -CH2-CH=		 2.03	
5		 α-CH2		 2.26	
6		 =CH-CH2-CH=		 2.78	
7		 Tentatively	assigned	to	CH2	lysyl	
protein		
3.03	
8		 (-N+(CH3)3)	Phosphatidylcholine)	 3.25	
9		 CH2-glyceryl	 4.15	
10		 Cho-α-CH2	
CH2-glyceryl	
4.35		
11	 -CH=CH-		 5.32	
Table	 1:	 Lipid	 proton	 contributions	 for	 high	DW	 spectra	with	 their	 assigned	 chemical	 group	 structure	 and	
spectral	position.	
	
	
Figure	2:	Example	of	human	muscle	diffusion	spectra	between	0.5	and	4.5ppm.	Blue:	summed	spectrum	with	
low	 DW	 showing	 small	 metabolite	 and	 strong	 lipid	 resonances;	 Red:	 summed	 spectrum	 with	 strong	 DW	
showing	 lipids	 only;	 Green:	 difference	 spectrum.	 Insert:	 zoomed	 region.	 Lipid	 resonances	 are	 assigned	
according	to	Table	1.	
	
3.2.2	Removal	of	lipid	contributions	from	CPMG	spectra	
1D	CPMG	spectra	can	be	acquired	fast	with	high	SNR.	Furthermore	-	as	introduced	earlier	-	
lipid	 signals	 are	 reduced	 in	 CPMG	 spectra,	 because	 of	 shorter	 T2	 compared	 to	 small	
metabolites,	 though	 lower	 lipid	 contributions	 remain.	 The	 diffusion-based	 lipid	 removal	
method	was	therefore	applied	on	standard	CPMG	spectra	 to	determine	 if	 these	remaining	
lipid	contributions	can	be	removed	by	subtracting	the	summed	20	high	DW	spectra	of	the	2D	
diffusion	 measurements	 from	 standard	 CPMG	 spectra.	 Thus,	 the	 effects	 of	 diffusion	 and	
relaxation	differences	were	combined.		
T2	 differences	 between	 lipid	 resonances	 (4)	 result	 in	 different	 signal	 intensities	 in	 CPMG	
spectra	compared	to	those	in	standard	2D	diffusion	measurements.	Therefore,	a	subtraction	
of	 the	 entire	 lipid	 spectrum	 after	 scaling	with	 a	 single	 factor	would	 leave	 remaining	 lipid	
signals,	depending	on	their	respective	T2	differences.	Instead,	a	specific	intensity	scaling	for	
each	resonance	 in	 the	high	DW	spectra	was	chosen	to	minimize	the	residue	(but	retaining	
frequency	and	line	width).	This	procedure	allows	for	an	effective	lipid	removal	(Fig.	3)	and	is	
similar	to	fitting	the	lipid	resonances;	however,	without	the	problem	to	include	resonances	
from	 small	 metabolites	 into	 the	 fit.	 The	 figure	 demonstrates	 that	 the	 lipid	 contributions	
underlying	some	of	the	small	metabolites	are	removed	to	a	large	extent.	However,	as	for	the	
subtraction	of	 the	high	 from	the	 low	DW	spectra,	 residual	artefacts	 remain	at	0.9	and	1.2	
ppm.		
	
	
Figure	 3:	 Example	 of	 human	 muscle	 spectra	 subtraction	 combining	 CPMG	 and	 diffusion	 spectra,	 using	
variable	scaling	of	the	lipid	resonances.	Blue:	CPMG	spectrum	(512	transients).	Green:	Difference	spectrum.	
	
3.3	1D	Diffusion-T2	filter	Measurements	for	lipid	removal	
3.3.1	Echo	Time	variations	–	Parameter	optimization	
In	 a	 first	 step,	 the	measurement	 parameters	 were	 optimized	 for	 the	 T2-filter	 part	 of	 our	
combined	 diffusion-CPMG	 sequence	 in	 order	 to	 find	 the	 best	 balance	 for	 the	 CPMG	
measurement	 between	 strong	 lipid	 reduction	 at	 longer	 echo	 times	 on	 one	 hand,	 and	
reduced	SNR,	potential	sample	heating	and	J-evolution	on	the	other	hand	(4).	Different	echo	
times	(TE)	were	tested	for	the	original	CPMG	sequence,	modifying	the	number	of	pulse	loops	
and	the	interpulse	delay	time	between	2	refocusing	pulses	for	each	loop	(Table	2).	Figure	4	
shows	 a	 comparison	 between	 four	 CPMG	 spectra	 from	 one	 pork	muscle	 biopsy	 acquired	
with	different	parameters	according	to	Table	2.	
	
	
	
	
Spectrum	
in	Fig.	4	
TE	
[ms]	
Number	
of	loops	
Interpulse	
delay	[ms]	
Comment	on	spectra	
1	–	red	 76.8	 192	 0.4	 No	visual	J-modulation,	good	SNR		
2	–	green	 152	 380	 0.4	 No	visual	 J-modulation,	slightly	decreased	
intensities,	stronger	decreased	lipids		
3	–	cyan	 152	 38	 4	 Strong	J-modulation	
4	–	blue	 760	 380	 2	 Lipids	 entirely	 suppressed,	 but	 J-
modulation	 and	 strong	 reduction	 of	
metabolite	intensities	
Table	2:	CPMG	parameters	applied	for	spectra	shown	in	Fig.	4	(different	TE,	number	of	loops	and	interpulse	
delay	time	for	each	loop	combination).		
		
Figure	4:	Example	of	pork	muscle	CPMG	spectra	acquired	with	different	parameters	(see	table	2),	all	spectra	
are	scaled	to	their	creatine	peak.	a)	Spectra	between	0.8	and	3.1ppm.	b)	Spectra	between	2.6	and	4.7ppm.	
b)	
a)	
	
Spectrum	 1	 (TE=76.8ms)	 and	 spectrum	 2	 (TE=152ms)	 appear	 quite	 similar	 despite	 the	
doubled	echo	time,	with	only	a	small	decrease	of	the	peak	intensity	for	the	longer	TE.	Both	
spectra	were	acquired	with	0.4ms	interpulse	delay	time	and	do	not	demonstrate	substantial	
J-modulation.		
		
Spectrum	 3	 was	 acquired	 at	 the	 same	 TE	 as	 spectrum	 2,	 but	 with	 a	 10-times	 longer	
interpulse	delay	 time	 (4ms).	 The	 strong	 J-evolution	 leads	 to	 complicated	 spectral	 patterns	
and	 reduced	signal	 intensities	 (visually	e.g.	at	1.5,	2.7	or	3.15	ppm)	hampering	metabolite	
quantification	 and	 inclusion	 in	 metabonomic	 analysis.	 The	 much	 greater	 difference	 of	
spectrum	3	compared	to	spectra	1	and	2	points	out	the	strong	impact	of	the	interpulse	delay	
time	for	each	loop	(see	also	(24)).	
	
Increasing	 the	echo	 time	to	760	ms	 reduced	considerably	 the	 lipid	content	and	yielded	an	
almost	 fat	 free	 spectrum	 (spectrum	4).	However,	metabolite	 resonances	were	 also	 clearly	
reduced	at	 this	 long	TE,	as	 seen	e.g.	at	 the	cysteine	multiplet	at	3.1ppm	which	disappears	
entirely	in	the	noise,	as	well	as	clear	intensity	decreases	of	resonances	between	3.5	and	3.8	
ppm	or	at	2.7	ppm.	Thus,	increasing	only	TE	appears	not	well	suited	for	complete	removal	of	
lipid	contributions,	because	of	low	SNR.	
	
In	conclusion,	the	results	of	the	interpulse	delay	time	and	TE	variation	in	the	original	CPMG	
sequence	 suggest	 that	 the	 combination	 of	 a	 CPMG	 sequence	 at	 moderate	 TE	 but	 short	
interpulse	 spacing	 with	 a	 DW	 module	 and	 subsequent	 lipid	 subtraction	 appears	 most	
promising	 for	 complete	 lipid	 removal	while	maintaining	 signals	 from	small	metabolites	 for	
analysis.	
	
3.3.2	1D	Diffusion-T2	filter	lipid	removal	
The	lipid	spectrum	subtraction	method	described	in	section	3.2	employed	summed	spectra	
with	 strong	 DW	 from	 a	 2D	 diffusion	 measurement.	 Since	 the	 results	 showed	 that	 the	
number	of	added	spectra	had	only	low	impact	on	spectral	lipid	contributions,	a	1D-diffusion	
measurement	would	 suffice	 for	 the	 lipid	 subtraction.	 The	 combination	of	 this	1D-diffusion	
preparation	 with	 an	 optimized	 CPMG	 T2-filter	 in	 one	 sequence	 eliminated	 residual	 lipids	
from	 the	muscle	 spectra,	which	were	 present	 in	 subtracted	 spectra	without	 the	 T2	 filter,	
thus	 permitting	 the	 separate	 analysis	 of	 a	 lipid	 free	metabolite	 and	 a	 pure	 lipid	 spectrum	
(Fig.	5).	
Figure	5:	1D	Diffusion-CPMG	spectra	of	a	pork	muscle	(blue	=	low	DW;	red	=	strong	DW;	green	=	difference).	
For	the	lipid	assignment,	see	Table	1.	
	
Figure	6:	1D	Diffusion-CPMG	spectra	of	a	sheep	brain	(blue	=	low	DW;	red	=	strong	DW;	green	=	difference).		
	
Similar	results	were	obtained	for	spectra	from	sheep	brain	biopsies,	though	with	much	less	
prominent	 lipids	 (Fig.6)	 and	 in	 spectra	 of	 human	 liver	with	 very	 strong	 lipid	 peaks	 (Fig.7);	
thus,	suggesting	that	this	method	is	applicable	in	various	tissue	types.		
For	the	liver	spectra,	a	residual	lipid	artefact	can	be	seen	at	1.2ppm	after	subtraction	(Fig.7),	
probably	 due	 to	 the	 very	 high	 amount	 of	 lipid	 with	 the	 -(CH2)n	 lipid	 peak	 being	 20	 times	
higher	than	the	creatine	peak	at	3.05ppm.	However,	the	lactate	peak	is	clearly	detectable	in	
the	subtracted	spectrum	and	appears	unaffected	from	lipids	(see	insert).	Lactate	could	thus	
be	included	in	the	metabonomic	analysis,	while	it	was	almost	hidden	by	lipids	in	the	original	
spectrum	(Fig.7	-	insert).		
	
	
Figure	 7:	 1D	Diffusion-CPMG	 spectra	 of	 a	 human	 liver	 sample	 (blue	 =	 low	DW;	 red	 =	 strong	DW;	 green	 =	
difference).	 For	 lipid	 assignment,	 see	 Table	 1.	 Insert:	 Zoom	on	 the	 1.15-1.45	 ppm	 region	 -	 The	 subtracted	
spectrum	is	increased	6	times	for	a	better	visualization	of	the	lactate	peak.	
	
The	 2D	 diffusion	 experiments	 permitted	 a	 flexible	 adjustment	 of	 strong	 and	 low	diffusion	
weighted	spectra	for	best	balance	between	metabolite	attenuation	and	SNR.	However,	after	
establishing	the	required	DW	for	optimal	lipid	removal,	1D-diffusion	measurements	may	be	
preferred	in	the	future	for	better	SNR	and	shorter	scan	times.	The	combined	diffusion-CPMG	
sequence	 yielded	 high	 quality	 small	metabolite	 and	 lipid	 spectra	with	 no	 obvious	 spectral	
impairment	 compared	 to	 a	 regular	 CPMG	 sequence	 and	 benefits	 from	 amplification	 of	
simultaneous	T2	and	diffusion	filters.	
	
3.4	Same-Needle	Biopsy	Analysis:	
Comparison	with	and	without	diffusion	spectroscopy	editing	
	
For	testing	the	potential	of	the	lipid	removal	procedure,	original	CPMG	spectra	of	repeated	
measurements	on	same	needle	biopsies	were	analyzed	and	compared	to	the	corresponding	
CPMG	 spectra	with	 lipid	 subtraction,	 using	 the	 resonance-specific	 scaling,	 as	 described	 in	
3.2.2.	
Principal	 Component	 Analyses	 (PCA)	 of	 the	 entire	 spectrum	 (Fig.8)	 without	 lipid	 removal	
demonstrated	 clustering	 for	 most	 of	 the	 same	 needle	 biopsies,	 both	 on	 PC1/PC2	 and	
PC2/PC3,	 indicating	 spectral	 similarities	 between	 them.	However,	 because	of	 considerable	
differences	 among	 same	 needle	 biopsies	 in	 few	 subjects	 there	 are	 no	 significant	 group	
differences	for	PC1	(p	=0.15),	PC2	(p	=0.23)	and	PC3	(p=0.05).		
	
	
Figure	8:	Same-needle	biopsy	analysis	without	lipid	subtraction	(left)	and	with	lipid	subtraction	(right).	
Up	:	PCA,	Down:	Loading	plots.	Red	ellipse:	95%	confidence	interval.	
	
The	PCA	results	reveal	one	biopsy	(S4)	outside	of	the	95%	confidence	interval	(Fig.8a),	and	
the	loading	plot	(Fig.8b)	 indicates	the	bucket	at	1.3	ppm	as	responsible	for	this	separation,	
which	is	most	likely	due	to	the	-(CH2)n	lipid	group	besides	lactate.	The	loading	plot	from	the	
PCA	using	non-subtracted	spectra	is	dominated	by	lipid	peaks	(despite	the	exclusion	of	pure	
lipid	regions	from	the	analysis)	and	therefore	reveals	the	possible	influence	of	lipid	content	
in	chemometric	analyses	for	metabolites	that	are	biased	by	underlying	lipid.		
The	analysis	was	repeated	after	lipid	subtraction	of	the	CPMG	spectra	in	order	to	reduce	the	
lipid	 contribution	on	 the	principal	 component	analysis	 separation.	The	PCA	 from	 the	 lipid-
removed	 spectra	 (Fig.8c)	 shows	 better	 clustering	 of	 same-needle	 biopsies	 (significant	 for	
PC2,	p=0.03),	as	well	as	a	more	homogenous	loading	plot	(Fig.8d).	Thus,	the	PCA	separation	
is	due	to	a	combination	of	different	metabolites	and	not	dominated	by	lipids	as	in	the	non-
subtracted	spectra.	The	two	biopsies	from	sample	S4	are	much	closer	to	each	other	after	the	
lipid	 removal	 than	 before,	 indicating	 that	 the	 two	 biopsies	 have	 a	 similar	metabolite	 but	
different	 lipid	 content.	 The	 results	 suggest	 that	 lipid	 removal	 in	 this	 reproducibility	 study	
a)	
b)	
c)	
d)	
Underlying	
lipids	
leads	 to	 clustering	 and	 group	 separation	 that	 is	 based	predominantly	 on	 small	metabolite	
differences	 instead	 of	 lipid	 contributions.	 If	 on	 the	 other	 hand	 lipid	 components	 are	 the	
focus	of	interest,	the	pure	lipid	spectra	used	for	subtraction	can	be	analysed	accordingly	in	
the	absence	of	small	metabolites.	
	
A	 secondary	 aim	 of	 this	 reproducibility	 study	 was	 to	 investigate	 how	 far	 the	 metabolite	
profile	of	a	single	biopsy	can	be	considered	representative	for	the	tissue	under	investigation.	
Same	needle	biopsies	harvested	 from	 the	 same	muscle	demonstrated	 similarities	 but	 also	
quite	surprisingly	strong	differences	 in	 the	metabolites	content	as	obtained	 from	HR-MAS.	
This	 variability	 needs	 to	 be	 taken	 into	 account	 in	 longitudinal	 HR-MAS	 studies	 on	muscle	
tissue	 but	 also	 for	 any	 other	 study	 that	 relies	 on	 the	 assumption	 that	 a	 biopsy	 sample	
represents	 a	 specific	 muscle	 type.	 It	 should	 be	 noted	 that	 the	 quite	 high	 variability	 also	
among	same	needle	biopsies	was	not	due	to	the	spectral	quality,	but	may	be	due	to	muscle	
fiber	 type	 composition	 (25).	 It	 has	 been	 suggested	 to	 use	 large	 biopsy	 samples	 to	 reduce	
intra-individual	 variation	 in	 the	 percentages	 of	 fast	 and	 slow	 fibers	 	 (26),	 although	 other	
studies	have	found	only	low	variation	in	fiber	type	distribution	within	single	biopsies	(27).		As	
discussed,	 a	 high	 variability	 in	 the	 lipid	 region	may	 occur	 and	 is	 probably	 due	 to	 varying	
inclusions	 of	 small	 residual	 contributions	 from	 extramyocellular	 lipid	 despite	 careful	
prevention	during	biopsy	harvesting.		
	
4.	Conclusion	
Spectra	 of	 biopsies	 from	 many	 different	 organs	 show,	 besides	 small	 metabolites,	 strong	
contributions	 from	 lipids,	 which	 often	 even	 dominate	 the	 spectra.	 This	 strongly	 impedes	
correct	 small	 metabolite	 quantification	 and	 metabonomic	 analysis.	 To	 overcome	 this	
problem,	we	took	advantage	of	diffusion	differences	between	small	metabolites	and	 lipids	
combined	with	T2	differences	to	obtain	lipid-free	spectra.		
A	 reproducibility	 study	 of	 same-needle	 muscle	 biopsy	 measurements	 demonstrated	 the	
applicability	 of	 the	 method	 and	 its	 potential	 value,	 by	 shifting	 the	 separation	 between	
groups	from	lipid	contributions	to	different	other	metabolites.		The	elimination	of	lipids	from	
the	HR-MAS	spectra	and	the	resulting	less	biased	assessment	of	small	metabolites	has	thus	
potential	 to	 remove	 ambiguities	 in	 the	 interpretation	 of	metabonomic	 results.	Moreover,	
the	diffusion	scans	permit	a	separate	 lipid	analysis	and	a	regular	diffusion	analysis	without	
expanding	measurement	time.		
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Supplementary	material	
#		 Reason	for	excluding	the	region	
1	 Lipid	&	Noise	
2		 Lipid	
3		 Lidocaine	contamination	
4		 Lipid	
5		 Pure	noise	
6		 Lipid	
7		 Lidocaine	contamination	&	Lipid	
8		 Lipid	
9		 Lipid	
10		 Lidocaine	contamination	
11	 Lipid	
12	 Water	residue	
13	 Lipid	
14	 Pure	noise	
15	 Pure	noise	
16	 Lidocaine	contamination	&	Noise	
17	 Pure	noise	
Table	S1:	Excluded	regions	from	figure	S1,	with	the	reasons	for	exclusion	
	
	
Figure	S1:	Muscle	spectrum	example,	with	the	excluded	regions	in	color,	labelled	according	to	Table	
S1.	
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